Lin et al. found that miR-22 was downregulated in synovial tissue of RA patients compared to that of OA patients, and that the levels of miR-22 were negatively correlated to the levels of Cyr61 overexpression and the promotion of IL-6 production [24]. This evidence concerns the gene CCN1 and rheumatoid arthritis.